Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth

DOI10.1142/S0218202521500299zbMath1473.92021arXiv2007.05098WikidataQ126914356 ScholiaQ126914356MaRDI QIDQ5164240

Elisabetta Rocca, Gabriela Marinoschi, Pierluigi Colli, Alessandro Reali, Guillermo Lorenzo, Héctor J. Gómez

Publication date: 10 November 2021

Published in: Mathematical Models and Methods in Applied Sciences (Search for Journal in Brave)

Full work available at URL: https://arxiv.org/abs/2007.05098

zbMATH Keywords

optimal controlsemilinear parabolic equationschemotherapyprostate cancerisogeometric analysisphase fieldcomputational oncology

Mathematics Subject Classification ID

Optimality conditions for problems involving partial differential equations (49K20) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Finite element, Rayleigh-Ritz and Galerkin methods for initial value and initial-boundary value problems involving PDEs (65M60) PDEs in connection with control and optimization (35Q93)

Related Items (16)

Well-posedness for a class of phase-field systems modeling prostate cancer growth with fractional operators and general nonlinearities ⋮ Tumor evolution models of phase-field type with nonlocal effects and angiogenesis ⋮ On the analysis of a mathematical model of CAR-T cell therapy for glioblastoma: insights from a mathematical model ⋮ Optimizing combination therapy in a murine model of HER2+ breast cancer ⋮ Optimal control of a model for brain lactate kinetics ⋮ On an optimal control problem describing lactate production inhibition ⋮ A hybrid spatiotemporal model of PCa dynamics and insights into optimal therapeutic strategies ⋮ Optimal control of an Allen-Cahn model for tumor growth through supply of cytotoxic drugs ⋮ Optimal distributed control for a viscous non-local tumour growth model ⋮ Optimal control of a reaction–diffusion model related to the spread of COVID-19 ⋮ Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent ⋮ Maximal regularity and optimal control for a non-local Cahn-Hilliard tumour growth model ⋮ Mathematical analysis of a model-constrained inverse problem for the reconstruction of early states of prostate cancer growth ⋮ On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: insights from a mathematical model ⋮ Optimal control of therapies on a tumor growth model with brain lactate kinetics ⋮ Modelling and simulation of anisotropic growth in brain tumours through poroelasticity: a study of ventricular compression and therapeutic protocols

Cites Work

• Unnamed Item
• Unnamed Item
• Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
• Provably unconditionally stable, second-order time-accurate, mixed variational methods for phase-field models
• Computational modeling of tumor-induced angiogenesis
• A spatial model of tumor-host interaction: application of chemotherapy
• Isogeometric analysis: CAD, finite elements, NURBS, exact geometry and mesh refinement
• Optimal control from theory to computer programs
• A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
• A generalized-\(\alpha\) method for integrating the filtered Navier-Stokes equations with a stabilized finite element method
• Optimal control of treatment time in a diffuse interface model of tumor growth
• Three-dimensional multispecies nonlinear tumor growth. II: Tumor invasion and angiogenesis
• Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
• Suitably graded THB-spline refinement and coarsening: towards an adaptive isogeometric analysis of additive manufacturing processes
• Long-time dynamics and optimal control of a diffuse interface model for tumor growth
• Optimal control of a phase field system modelling tumor growth with chemotaxis and singular potentials
• Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
• Hierarchically refined and coarsened splines for moving interface problems, with particular application to phase-field models of prostate tumor growth
• Selection and validation of predictive models of radiation effects on tumor growth based on noninvasive imaging data
• Optimal control for a mathematical model for anti-angiogenic treatment with Michaelis-Menten pharmacodynamics
• A mathematical model of low grade gliomas treated with temozolomide and its therapeutical implications
• Sliding mode control for a phase field system related to tumor growth
• Selection, calibration, and validation of models of tumor growth
• A hybrid ten-species phase-field model of tumor growth
• A Time Integration Algorithm for Structural Dynamics With Improved Numerical Dissipation: The Generalized-α Method
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
• ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
• GENERAL DIFFUSE-INTERFACE THEORIES AND AN APPROACH TO PREDICTIVE TUMOR GROWTH MODELING
• GMRES: A Generalized Minimal Residual Algorithm for Solving Nonsymmetric Linear Systems
• Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies
• A hybrid three-scale model of tumor growth
• Mathematical analysis and simulation study of a phase-field model of prostate cancer growth with chemotherapy and antiangiogenic therapy effects
• Optimal distributed control of a diffuse interface model of tumor growth

This page was built for publication: Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth